172 related articles for article (PubMed ID: 18815549)
21. Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers.
Minhajat R; Mori D; Yamasaki F; Sugita Y; Satoh T; Tokunaga O
Pathol Int; 2006 Dec; 56(12):717-23. PubMed ID: 17096728
[TBL] [Abstract][Full Text] [Related]
22. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions.
Ding S; Li C; Lin S; Yang Y; Liu D; Han Y; Zhang Y; Li L; Zhou L; Kumar S
Hum Pathol; 2006 Jul; 37(7):861-6. PubMed ID: 16784986
[TBL] [Abstract][Full Text] [Related]
23. Endoglin (CD 105) is expressed on endothelial cells in the primary central nervous system lymphomas and correlates with survival.
Sugita Y; Takase Y; Mori D; Tokunaga O; Nakashima A; Shigemori M
J Neurooncol; 2007 May; 82(3):249-56. PubMed ID: 17102906
[TBL] [Abstract][Full Text] [Related]
24. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium?
Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S
Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306
[TBL] [Abstract][Full Text] [Related]
25. Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma.
Yu D; Zhuang L; Sun X; Chen J; Yao Y; Meng K; Ding Y
BMC Cancer; 2007 Jul; 7():122. PubMed ID: 17608955
[TBL] [Abstract][Full Text] [Related]
26. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma.
Saad RS; El-Gohary Y; Memari E; Liu YL; Silverman JF
Hum Pathol; 2005 Sep; 36(9):955-61. PubMed ID: 16153457
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
Raica M; Cimpean AM; Anghel A
Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
[TBL] [Abstract][Full Text] [Related]
28. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
Li Q; Zhang B; Peng P
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
[TBL] [Abstract][Full Text] [Related]
29. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
[TBL] [Abstract][Full Text] [Related]
30. The role of angiogenin in pT1-T2 tongue carcinoma neo-angiogenesis and cell proliferation: an exploratory study.
Marioni G; Staffieri A; Fasanaro E; Stramare R; Giacomelli L; Bernardi E; Val M; Stellini E; de Filippis C; Blandamura S
J Oral Pathol Med; 2013 Sep; 42(8):606-11. PubMed ID: 23432607
[TBL] [Abstract][Full Text] [Related]
31. Angiogenic factors in squamous cell carcinoma of the oral cavity: do they have prognostic relevance?
Schimming R; Reusch P; Kuschnierz J; Schmelzeisen R
J Craniomaxillofac Surg; 2004 Jun; 32(3):176-81. PubMed ID: 15113577
[TBL] [Abstract][Full Text] [Related]
32. Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma.
Kyzas PA; Agnantis NJ; Stefanou D
Virchows Arch; 2006 Jun; 448(6):768-75. PubMed ID: 16612622
[TBL] [Abstract][Full Text] [Related]
33. Overexpressions of DLL4 and CD105 are Associated with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma.
Zhou L; Yu L; Ding G; Chen W; Zheng S; Cao L
Pathol Oncol Res; 2015 Sep; 21(4):1141-7. PubMed ID: 25986715
[TBL] [Abstract][Full Text] [Related]
34. CD105/endoglin expression in Gorham disease of bone.
Franchi A; Bertoni F; Bacchini P; Mourmouras V; Miracco C
J Clin Pathol; 2009 Feb; 62(2):163-7. PubMed ID: 19181633
[TBL] [Abstract][Full Text] [Related]
35. Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanoma.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1998; 18(4A):2701-10. PubMed ID: 9703932
[TBL] [Abstract][Full Text] [Related]
36. Endoglin (CD105): a marker of tumor vasculature and potential target for therapy.
Dallas NA; Samuel S; Xia L; Fan F; Gray MJ; Lim SJ; Ellis LM
Clin Cancer Res; 2008 Apr; 14(7):1931-7. PubMed ID: 18381930
[TBL] [Abstract][Full Text] [Related]
37. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer.
Saad RS; Liu YL; Nathan G; Celebrezze J; Medich D; Silverman JF
Mod Pathol; 2004 Feb; 17(2):197-203. PubMed ID: 14657950
[TBL] [Abstract][Full Text] [Related]
38. CD105 is important for angiogenesis: evidence and potential applications.
Duff SE; Li C; Garland JM; Kumar S
FASEB J; 2003 Jun; 17(9):984-92. PubMed ID: 12773481
[TBL] [Abstract][Full Text] [Related]
39. Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neo-vascularization.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1998; 18(5A):3621-8. PubMed ID: 9858949
[TBL] [Abstract][Full Text] [Related]
40. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
Zhou S; Wang GP; Liu C; Zhou M
BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
